C1q肿瘤坏死因子相关蛋白9(C1QTNF9)多克隆抗体
Polyclonal Antibody to C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)
CTRP9; C1QTNF9A; AQL1; Complement C1q and tumor necrosis factor-related protein 9A
- 编号PAR877Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPR877Hu01-C1q肿瘤坏死因子相关蛋白9(C1QTNF9)重组蛋白
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度0.5mg/ml
- 且适物种Mus musculus (Mouse,小鼠)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 695 ¥ 1621 ¥ 2316 ¥ 5790 ¥ 23160
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对C1QTNF9的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别C1QTNF9。
用法
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPR877Hu01 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAR877Hu01 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)多克隆抗体 | WB; IHC; ICC; IP. |
MAR877Hu21 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)单克隆抗体 | WB; IHC; ICC; IP. |
SER877Hu | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMR877Hu | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Int J Obes (Lond). | Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. [Pubmed: 24357853] |
J Clin Endocrinol Metab.? | Association of Serum C1q/TNF-Related Protein-9 Concentration With Arterial Stiffness in Subjects With Type 2 Diabetes [Pubmed:25105737] |
J Clin Endocrinol Metab. | C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery [Pubmed:26982010] |
PLoS One. | Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. [pubmed:28207876] |
Journal of Diabetes Research | Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients withType 2 Diabetes without Renal Dysfunction. [pubmed:28070523] |
diabetes research and clinical practice | Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance [pubmed:28743061] |
PLoS One | Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery … [Pubmed:29381773] |
archives of insect biochemistry and physiology | Effect of a single bout of resistance exercise on zinc-α2-glycoprotein [Pubmed: 31686532] |
J Diabetes Investig | Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus [33417302] |
Neurol Ther | Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke [34727346] |
留言咨询